Resveratrol and health – A comprehensive review of human clinical trials
- 20 June 2011
- journal article
- review article
- Published by Wiley in Molecular Nutrition & Food Research
- Vol. 55 (8) , 1129-1141
Abstract
In the past decade, the small polyphenol resveratrol has received widespread attention as either a potential therapy or as a preventive agent for numerous diseases. Studies using purified enzymes, cultured cells, and laboratory animals have suggested that resveratrol has anti‐aging, anti‐carcinogenic, anti‐inflammatory, and anti‐oxidant properties that might be relevant to chronic diseases and/or longevity in humans. Although the supporting research in laboratory models is quite substantial, only recently data has emerged to describe the effects of resveratrol supplementation on physiological responses in humans. The limited number of human clinical trials that are available has largely described various aspects of resveratrol's safety and bioavailability, reaching a consensus that it is generally well‐tolerated, but have poor bioavailability. Very few published human studies have explored the ability of resveratrol to achieve the physiological benefits that have been observed in laboratory models, although many clinical trials have recently been initiated. This review aims to examine the current state of knowledge on the effects of resveratrol on humans and to utilize this information to develop further guidelines for the implementation of human clinical trials.Keywords
This publication has 80 references indexed in Scilit:
- Pleiotropic mechanisms facilitated by resveratrol and its metabolitesBiochemical Journal, 2010
- Effect of exercise training on chronic inflammationClinica Chimica Acta, 2010
- Resveratrol, sirtuins, and the promise of a DR mimeticMechanisms of Ageing and Development, 2010
- Resveratrol reduces endothelial progenitor cells senescence through augmentation of telomerase activity by Akt‐dependent mechanismsBritish Journal of Pharmacology, 2008
- Oxidants and the pathogenesis of lung diseasesJournal of Allergy and Clinical Immunology, 2008
- Mitochondrial biogenesis and healthy agingExperimental Gerontology, 2008
- Resveratrol Delays Age-Related Deterioration and Mimics Transcriptional Aspects of Dietary Restriction without Extending Life SpanCell Metabolism, 2008
- Resveratrol improves health and survival of mice on a high-calorie dietNature, 2006
- Therapeutic potential of resveratrol: the in vivo evidenceNature Reviews Drug Discovery, 2006
- Transcriptional co-activator PGC-1α drives the formation of slow-twitch muscle fibresNature, 2002